The Patents Court in the UK has determined that one of Boston Scientific’s patents related to outer seals for transcatheter heart valves that was asserted against the SAPIEN 3 valve is invalid, while a second patent is valid and infringed.
According to a company release, Edwards will request an appeal on specific aspects of the decision, and believes that the company will ultimately prevail. The decision does not affect commercial availability of the SAPIEN 3 valve.
Boston Scientific initiated litigation that now involves multiple patents in multiple venues, and will likely yield court actions over an extended period of time. The company is not changing its financial guidance.